Positive Outlooks Blog

News and stories that make you feel better after reading.

  • Home
  • About Us
  • Stories
    • Travel
    • Health
    • Reflections
    • Quotes
  • Submit Your Story
  • Contact Us
  • Home
  • pharmaceutical innovation

Nasal spray could help those who have no success with available depression treatments

Recently, the U.S. FDA approved esketamine, a fast-acting drug derived from the anesthetic, ketamine, that is intended to aid the treatment-resistant population of people with depression. There are about 16.2 million Americans who suffer from major depression, and as many as a quarter of them reported achieving little to no results from available treatments, including FDA

Read more →

Tagged with 
depression esketamine health Janssen Pharmaceuticals Johnson & Johnson ketamine medical treatment medicines pharmaceutical innovation science Spravato
 




Archives
Join Our Mailing List

We will send our inspiring stories straight to your inbox. PLEASE remember that you can manage your subscription by weekly, daily or once in a day. You are in control how you receive our stories.

Join 35,560 other subscribers

Advertisements
Collection of quotes that offer wisdom and hope:
Our Top Stories:
After divorce, woman restarts her life in a tiny home with an amazing hidden shower
4-year-old girl with Down syndrome can't stop smiling as she walks in fashion show
What is panic attack and 10 ways to deal with it
If you’re missing someone this Christmas this song is dedicated to you
Country singers love this classic song, Lukas Nelson's version goes viral
Elderly lady refused to come near neighbor's 'scary' dog — until he saved her life




Privacy Policy of Positive Outlooks